SN · Pharma and healthcare · one day
Smith & Nephew (SN): news on Tuesday 17 November 2026
News from the 24 hours to Tuesday morning, 17 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage was light, with a share price note showing the stock little changed and a commentary piece asking whether it could stand out as investors rotate. The tone is mildly positive but low-impact.
What drove it
- flat share price
- market rotation commentary
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Thu 12 Nov | +0.8 | 5 |
| Fri 13 Nov | −5.7 | 3 |
| Sat 14 Nov | 0.0 | 1 |
| Tue 17 Nov | +2.0 | 2 |
| Wed 18 Nov | +4.8 | 3 |
1 story · 2 headlines · strongest first
Pharma and healthcare on 17 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Smith & Nephew market watch commentary +2.52 headlines today · 7 in all, since 12 November · Pieces comment on Smith & Nephew's market position and share price of 1,176p. | ||
| +4.2 | Commentary suggesting the stock may attract interest amid market rotation. | |
| 0.0 | Share price report showing almost no movement on the day. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Smith & Nephew: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.